FREEHOLD, N.J., April 15 /PRNewswire-FirstCall/ -- Speedus Corp.
(Nasdaq: SPDE), today announced that on April 12, 2010 it received notice that the NASDAQ
Hearings Panel (the "Panel") granted the Company the maximum
allowable extension to regain compliance with Listing Rule 5550(b)
(the “Rule”), which requires stockholders’ equity of at least
$2.5 million. The Panel's decision
follows the hearing that took place on March
11, 2010, at which time Speedus' management presented the
Panel with a plan for regaining and sustaining compliance with the
Rule.
About Speedus Corp.
Speedus Corp. (NASDAQ: SPDE) operates through its two majority
subsidiaries, Zargis Medical Corp. and Density Dynamics, Inc.
Additional information on Speedus Corp. may be obtained at
www.speedus.com or by contacting Peter
Hodge at 888-773-3669 (ext. 23) or phodge@speedus.com.
Statements contained herein that are not historical facts,
including but not limited to statements about the Company's
product, corporate identity and focus, may be forward-looking
statements that are subject to a variety of risks and
uncertainties. There are a number of important factors that could
cause actual results to differ materially from those expressed in
any forward-looking statements made by the Company, including, but
not limited to, the continuing development of the Company's sales,
marketing and support efforts.
SOURCE Speedus Corp.
